Bright Minds Biosciences (DRUG): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek Bright Minds Biosciences (DRUG)

Bright Minds Biosciences (DRUG) is developing a biopharmaceutical cluster of targeted therapies to combat depression and CNS pathologies. Earnings per share over the last four quarters demonstrate financial dynamics where -2.08 expresses the current value of the metric. Management is focused on creating safe serotonin-based drugs for epilepsy. High long-term market potential is driven by demand for medications without hallucinogenic effects.

DRUG (Bright Minds Corp) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 16.11.2026

Rincian analitis lan laporan data perusahaan Bright Minds Biosciences Inc (DRUG)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:DRUG - Bright Minds Biosciences Inc.
Produk seri Bright Minds Bio

For Bright Minds Biosciences (DRUG), whose market capitalization depends on the success of psychedelic clinical trials, this indicator serves as a measure of effectiveness in overcoming a financial crisis. By analyzing the 12-month net income per share snapshot on the GURU.Markets platform, an investor sees the result of dividing total net income by the number of shares, which allows for an assessment of the business's real value and prevents overpaying for the asset.